Co‑founder & CEO, Opalite Health · AI interpreter in 150+ languages · YC W26
San Francisco Bay Area, CA
Work formatOfficeHybridRemoteEverything above is an outside read of where you've been. This is the one block you write yourself — the direction you're steering toward.
YC‑backed founder building an AI interpreter with live EHR integrations signals strong product and technical coordination in healthcare. Published neuro‑oncology ML work and research roles at UBNS/JHU support credibility interfacing between clinicians and engineering. Early investor traction suggests capacity to fundraise and tell the story.
Career trajectory
Read purely by the companies on record — the same shortcut a recruiter takes.
founder / CEO
researcher (student)
researcher (affiliated)
Unconfirmed
Moves from student research roles into founding a YC‑backed healthtech company — from academic operator to founder/CEO.
AscendingThe Johns Hopkins affiliation appears via aggregators; confirm lab role and dates to lock the slope.
Everything above is an outside read of where you've been. This is the one block you write yourself — the direction you're steering toward.
YC‑backed founder building an AI interpreter with live EHR integrations signals strong product and technical coordination in healthcare. Published neuro‑oncology ML work and research roles at UBNS/JHU support credibility interfacing between clinicians and engineering. Early investor traction suggests capacity to fundraise and tell the story.
Career trajectory
Read purely by the companies on record — the same shortcut a recruiter takes.
founder / CEO
researcher (student)
researcher (affiliated)
Unconfirmed
Moves from student research roles into founding a YC‑backed healthtech company — from academic operator to founder/CEO.
AscendingThe Johns Hopkins affiliation appears via aggregators; confirm lab role and dates to lock the slope.
Building Opalite Health’s AI medical interpreter and integrations with leading EHRs, and working with early healthcare customers.
Building Opalite Health’s AI medical interpreter and integrations with leading EHRs, and working with early healthcare customers.
I help healthtech teams translate clinical needs into shipping products — from workflow mapping and EHR integration paths to getting clinicians to first value. I’ve built and validated an AI medical interpreter across 150+ languages and navigated YC, early fundraising, and healthcare go‑to‑market.
If you’re tackling provider workflows, I can share what works for pilots, procurement, and closing. On the research side, I can bridge clinicians and data teams on applied ML in neuro‑oncology and beyond.
›Designing EHR‑connected pilots that win clinical champions
›Translating clinical workflows into tractable AI features
›Publishing applied ML tools alongside clinical collaborators
I help healthtech teams translate clinical needs into shipping products — from workflow mapping and EHR integration paths to getting clinicians to first value. I’ve built and validated an AI medical interpreter across 150+ languages and navigated YC, early fundraising, and healthcare go‑to‑market.
If you’re tackling provider workflows, I can share what works for pilots, procurement, and closing. On the research side, I can bridge clinicians and data teams on applied ML in neuro‑oncology and beyond.
›Designing EHR‑connected pilots that win clinical champions
›Translating clinical workflows into tractable AI features
›Publishing applied ML tools alongside clinical collaborators
Founder-CEO of Opalite Health (YC W26), building an AI medical interpreter across 150+ languages with live EHR integrations. Early investors include 007 Venture Partners, with Opalite listed in Robinhood Ventures Fund II filings; YC backing further validates the venture. Published first‑author work in Journal of Neurosurgery: Pediatrics on a machine‑learning survival calculator for medulloblastoma. Trained and worked in research roles at UB Neurosurgery and a Johns Hopkins neuro‑oncology outcomes lab before deferring residency to pursue the startup. Public footprint includes podcast interviews and invited speaking on AI in healthcare.
Founder-CEO of Opalite Health (YC W26), building an AI medical interpreter across 150+ languages with live EHR integrations. Early investors include 007 Venture Partners, with Opalite listed in Robinhood Ventures Fund II filings; YC backing further validates the venture. Published first‑author work in Journal of Neurosurgery: Pediatrics on a machine‑learning survival calculator for medulloblastoma. Trained and worked in research roles at UB Neurosurgery and a Johns Hopkins neuro‑oncology outcomes lab before deferring residency to pursue the startup. Public footprint includes podcast interviews and invited speaking on AI in healthcare.
An outside read, based on the evidence found.
This reads as a clinician‑founder early in her career who pivoted from academic neuro‑oncology research to build a YC‑backed healthtech product — an AI medical interpreter with EHR hooks. There’s credible research output and visible early investor backing, plus an active public presence through YC, a podcast, and talks. The record is still light on long operating history, licensure, and enterprise customer proofs — consistent with an early‑stage founder profile.
YC Winter 2026 backing and live product/docs for a 150+ language medical interpreter with EHR integrations anchor the profile.
Top‑tier accelerator signal
Y Combinator lists Opalite Health in Winter 2026.
Product evidence, not just slides
Live product page and EHR developer docs detail real integrations.
Early investor validation
007 Venture Partners post and RVII SEC filing cite Opalite.
No NPI/license surfaced and ‘trained as a neurosurgeon’ appears in investor marketing without residency roster confirmation.
Brand shift from Calliope to Opalite App Store and historical email domain suggest an early rebrand/pivot.
Taiwan upbringing Company bio mentions growing up in Taiwan — useful for context and language.
Peer‑reviewed ML publication First‑author neuro‑oncology ML paper strengthens technical credibility.
An outside read, based on the evidence found.
This reads as a clinician‑founder early in her career who pivoted from academic neuro‑oncology research to build a YC‑backed healthtech product — an AI medical interpreter with EHR hooks. There’s credible research output and visible early investor backing, plus an active public presence through YC, a podcast, and talks. The record is still light on long operating history, licensure, and enterprise customer proofs — consistent with an early‑stage founder profile.
YC Winter 2026 backing and live product/docs for a 150+ language medical interpreter with EHR integrations anchor the profile.
Top‑tier accelerator signal
Y Combinator lists Opalite Health in Winter 2026.
Product evidence, not just slides
Live product page and EHR developer docs detail real integrations.
Early investor validation
007 Venture Partners post and RVII SEC filing cite Opalite.
No NPI/license surfaced and ‘trained as a neurosurgeon’ appears in investor marketing without residency roster confirmation.
Brand shift from Calliope to Opalite App Store and historical email domain suggest an early rebrand/pivot.
Taiwan upbringing Company bio mentions growing up in Taiwan — useful for context and language.
Peer‑reviewed ML publication First‑author neuro‑oncology ML paper strengthens technical credibility.
Web sources + resume claims.
Opalite Health, Inc. — Co‑Founder & CEO
Verified · 3 sourcesPresent
Co‑founded and leads Opalite Health (YC W26), delivering a real‑time AI medical interpreter in 150+ languages with EHR‑connected workflows.
University at Buffalo Neurosurgery (UBNS) — Medical Student Researcher
Verified · 2 sourcesContributed to outcomes modeling; co‑authored an online ML survival calculator for pediatric medulloblastoma published in J Neurosurg Pediatrics (2023).
Johns Hopkins neuro‑oncology surgical outcomes lab — Researcher (affiliated)
Verified · 2 sourcesWorked on neuro‑oncology outcomes research; co‑authored works listed with Johns Hopkins affiliations.
Web sources + resume claims.
Opalite Health, Inc. — Co‑Founder & CEO
Verified · 3 sourcesPresent
Co‑founded and leads Opalite Health (YC W26), delivering a real‑time AI medical interpreter in 150+ languages with EHR‑connected workflows.
University at Buffalo Neurosurgery (UBNS) — Medical Student Researcher
Verified · 2 sourcesContributed to outcomes modeling; co‑authored an online ML survival calculator for pediatric medulloblastoma published in J Neurosurg Pediatrics (2023).
Johns Hopkins neuro‑oncology surgical outcomes lab — Researcher (affiliated)
Verified · 2 sourcesWorked on neuro‑oncology outcomes research; co‑authored works listed with Johns Hopkins affiliations.
Real‑time AI medical interpreter across 150+ languages; EHR‑connected workflows.
Student‑driven predictive app exploring ML‑based medical prognoses; listed on team and legal/IP pages.
Real‑time AI medical interpreter across 150+ languages; EHR‑connected workflows.
Student‑driven predictive app exploring ML‑based medical prognoses; listed on team and legal/IP pages.
Invited speaker at Dent Dialog AI Forum (Dent Capital).
Guest on The Vesting Show podcast discussing founding Opalite Health.
Y Combinator W26 company page lists Opalite Health and founders.
Invited speaker at Dent Dialog AI Forum (Dent Capital).
Guest on The Vesting Show podcast discussing founding Opalite Health.
Y Combinator W26 company page lists Opalite Health and founders.
Each read pairs a strength with a tension.
Each read pairs a strength with a tension.
J Neurosurg Pediatrics (2023) — ML survival calculator for medulloblastoma
J Neurosurg Pediatrics (2023) — ML survival calculator for medulloblastoma
University at Buffalo, Jacobs School of Medicine and Biomedical Sciences
MD · Medicine · 2025
Commencement program notes 'Deferred Residency'.
Tulane University
BS · Neuroscience
University at Buffalo, Jacobs School of Medicine and Biomedical Sciences
MD · Medicine · 2025
Commencement program notes 'Deferred Residency'.
Tulane University
BS · Neuroscience
Government filings (2)
Press & interviews (9)
Corporate & product (9)
Verification checks — ran clean (4)
Social & directories (6)
Government filings (2)
Press & interviews (9)
Corporate & product (9)
Verification checks — ran clean (4)
Social & directories (6)
Cathleen Kuo, MD works as Co‑Founder & CEO at Opalite Health, Inc., based in San Francisco Bay Area, CA.
Cathleen Kuo, MD is a healthtech founder known for leading Opalite Health (YC W26) and publishing neurosurgery ML research.
Building Opalite Health’s AI medical interpreter and integrations with leading EHRs, and working with early healthcare customers.
Cathleen Kuo, MD has worked at 3 companies on record:
Projects and ventures Cathleen Kuo, MD is behind:
Skills listed on Cathleen Kuo, MD's profile: healthtech founder (MD). I help healthtech teams translate clinical needs into shipping products — from workflow mapping and EHR integration paths to getting clinicians to first value. Can teach: Designing EHR‑connected pilots that win clinical champions; Translating clinical workflows into tractable AI features; Publishing applied ML tools alongside clinical collaborators.
Cathleen Kuo, MD is open to enterprise pilot intros, health system partnerships, advisor intros and seed/venture conversations.
Cathleen Kuo, MD's education:
Public mentions of Cathleen Kuo, MD:
Cathleen Kuo, MD's public sites and channels:
This profile is assembled from 26 public sources, last aggregated 2026-10-05. Every fact carries a label: Verified (backed by two or more independent sources), Vouched (confirmed by a person who worked with them) or Self-reported. 5 facts are confirmed by cited sources. It is a public-source professional profile, not a background check.
Controlled by Cathleen Kuo, MD
A registered account is linked to this profile — a living profile a real person maintains, not a passive scrape.
